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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma (NPC) is the most common malignant tumor of the nasopharynx. 
Radiotherapy is a therapy of choice for NPC that has been recognized for a long time and used in various centers 
of the world. However, radiotherapy is known to still have an adverse effect. It is common practice to evaluate 
Complete Blood Count (CBC) before, during, and after radiotherapy. However, there has been no study 
regarding the effect of radiotherapy on all CBC parameters. This study aims to analyze the effect of radiotherapy 
on CBC in NPC patients before and after radiotherapy treatment. 
Method: This study was an observational study using secondary data from medical records at the radiotherapy 
outpatient clinic at Dr. Soetomo General Hospital Surabaya. The subject of this study was patients with NPC 
who underwent a full cycle of radiotherapy treatment on radiotherapy outpatient clinic in 2016. Patients with 
incomplete medical records and did not finish the radiotherapy treatment were excluded. A paired T-test and 
Wilcoxon signed-rank test were used for statistical analysis. 
Result: There were 105 patients included in this study. Mean Corpuscular Hemoglobin Concentration (MCHC), 
total leucocyte, lymphocyte, and thrombocyte was significantly decreased after a full cycle of radiotherapy (all 
P<0.05). Eosinophil, basophil, neutrophil, monocyte, Neutrophil to Lymphocyte ratio (NLR), and Platelet to 
Lymphocyte ratio (PLR) was significantly increased after a full cycle of radiotherapy (all P<0.05). 
Conclusion: Radiotherapy had a significant effect on the CBC parameter in NPC patients. 
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1. INTRODUCTION 
Nasopharyngeal carcinoma (NPC) is the most common malignant 
tumor of the nasopharynx. Globally, NPC is uncommon cancer with 
approximately 80,000 new cases reported per year and accounting 0.7% of 
all cancers  [1]. In Indonesia, NPC is the most common malignancy in the 
head and neck, and, the 4th most common cancer after cervical, breast, and 
skin cancer. The estimated incidence of NPC nationwide is 5.66/100,000 
population, and East Java region had the highest incidence (16.42/100,000 
population). In Surabaya the estimated incidence of NPC is 7.23/100, 000 
population [2]. 
Radiotherapy is a therapy of choice for NPC that has been recognized 
for a long time and used in various centers in the world. It can be given as 
definitive and or palliative which can be followed by symptomatic 
chemotherapy according to symptoms to provide improving tumor control 
and survival rate in advanced stage NPC [3]. However, this procedure has 
adverse effects. In the acute phase, it can be mucositis, dermatitis, 
xerostomia and in the late phase, it can be soft tissue fibrosis, trismus, 
xerostomia, hearing loss, vasculopathy, osteoradionecrosis, temporal lobe 
necrosis, hypothyroidism, hypopituitarism [4]. For the systemic adverse 
effect, one of the most common symptoms experienced by patients is fatigue 
that considered as radiotherapy-related fatigue [5] 
Studies about the evaluation of NPC patients' conditions that undergo 
radiotherapy in Indonesia are still minimal. Complete blood examination 
(CBC) is routinely measured to evaluate the condition of NPC patients who 
undergo radiotherapy. It is chosen because it is fast, inexpensive, and has a 
practical functional index. Moreover, the CBC could reflect the biological 
characteristics of tumor cells indirectly and combining it with the TNM 
stage is very useful for building a more accurate predicting system of NPC 
patients' individualized outcomes [6]. However, there has been no study 
regarding the effect of radiotherapy on the CBC parameter. This study aims 
to analyze the effect of radiotherapy on CBC in NPC patients before and 
after radiotherapy treatment. 
2. MATERIAL AND METHODS 
This study was an observational study using secondary data from 
medical records at the radiotherapy outpatient clinic at Dr. Soetomo General 
Hospital Surabaya, a tertiary referral hospital for the eastern part of 
Indonesia. Ethical approval from the Research Ethics Committee was 
received before the study begins (Ethical Approval Number: 
639/panke.KKE/XI/2017). This study has been performed in accordance 
with the Declaration of Helsinki. 
The subject of this study was patients with NPC who underwent 
radiotherapy treatment on radiotherapy outpatient clinic. Inclusion criteria 
were NPC patients who underwent radiotherapy in 2016 from the first cycle 
until the last cycle and had done laboratory evaluation before after 
radiotherapy treatment. Exclusion criteria were patients with incomplete 
medical records and did not finish the radiotherapy treatment. CBC 
evaluation was done at the same hospital. NPC staging was based on the 7th 
edition of the International Union against Cancer/American Joint 
Committee on Cancer (UICC/AJCC) staging system [7]. 
Acquired data were analyzed with SPSS 17.0.0 for Windows, 2007, 
SPSS Inc. Chicago, IL, USA. Data distribution was analyzed using the 
Kolmogorov-Smirnov test. Laboratory evaluation data was presented in 
mean ± SD and analyzed using paired T-test or Wilcoxon signed-rank test. 
A P-value of <0.05 was considered statistically significant. 
3. RESULT 
There were 260 patients underwent radiotherapy treatment in 2016 at 
radiotherapy outpatient clinic Dr. Soetomo General Hospital. From all 
patients, only 105 fulfill the inclusion criteria and did not fulfill the 
exclusion criteria. Based on gender, 68 patients were male and 37 patients 
were female. Patient's ages ranged from 8 to 69 year old, with a mean of 
46.18±12.25 year old.  The majority of patients were already in the late 
stage, only 17 patients were in the early stage (table 1). 
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Table 1. Characteristic of the Study Subjects 
Characteristic 
N = 105  
n (%) 
Gender 
Male 
Female 
 
 
68 (64.8) 
37 (35.2) 
Age (mean ± SD) 
< 18 years old 
18 – 59 years old 
≥ 60 years old 
46.18±12.25 
4 (3.8) 
92 (87.6) 
9 (8.6) 
Staging 
1 
2 
3 
4a 
4b 
 
1 (1) 
16 (15.2) 
19 (18.1) 
64 (61) 
5 (4.8) 
 
The CBC parameter was evaluated for data distribution normality using 
the Kolmogorov-Smirnov test. Effect of radiotherapy on Hemoglobin and 
Mean Corpuscular Hemoglobin Concentration was analyzed using paired T-
test, while other parameters were evaluated using the Wilcoxon signed-rank 
test. Mean Corpuscular Hemoglobin Concentration (MCHC), total 
leucocyte, lymphocyte, and thrombocyte was significantly decreased after a 
full cycle of radiotherapy (all P<0.05). On the other hand, eosinophil, 
basophil, neutrophil, monocyte, Neutrophil to Lymphocyte ratio (NLR), and 
Platelet to Lymphocyte ratio (PLR) was significantly increased after a full 
cycle of radiotherapy (all P<0.05). Hemoglobin, erythrocyte, hematocrit, 
mean corpuscular volume, mean corpuscular hemoglobin and mean platelet 
volume did not change significantly after the treatment (table 2). 
 
Table 2. Complete Blood Count Parameter Evaluation Before and After Full 
Cycle Radiotherapy 
Complete Blood Count 
Parameter 
Before radiotherapy After radiotherapy P 
Hemoglobin (g/dL) 12.13±1.62 11.90±1.23 0.066# 
Erythrocyte 4.20±0.62 4.53±3.97 0.505+ 
Hematocrit 36.47±5.66 36.07±4.51 0.461+ 
MCV 87.23±10.70 88.57±6.15 0.366+ 
MCH 29.58±6.60 28.91±2.24 0.261+ 
MCHC 32.90±1.19 32.64±1.31 0.049#* 
Total Leucocyte 8.09±4.88 6.61±2.46 < 0.001+* 
Eosinophil 3.26±3.73 5.39±5.93 < 0.001+* 
Basophil 0.62±0.38 0.65±1.45 0.022+* 
Neutrophil 61.94±13.03 74.53±9.21 < 0.001+* 
Lymphocyte 25.61±11.05 11.04±5.11 0.139+* 
Monocyte 8.27±3.89 8.57±2.41 < 0.001+* 
Thrombocyte 318.01±120.17 275.17±86.67 < 0.001+* 
MPV 13.59±46.98 8.44±1.58 0.367+ 
NLR 3.25±2.58 9.08±6.90 < 0.001+* 
PLR 2.04±1.34 4.91±2.87 < 0.001+* 
*P < 0.05 was considered statistically significant 
#Paired T-test was used 
+Wilcoxon signed rank test was used 
MCV = Mean Corpuscular Volume; MCH = Mean Corpuscular Hemoglobin; MCHC = Mean 
Corpuscular Hemoglobin Concentration; MPV = Mean Platelet Volume; NLR = Neutrophil to 
Lymphocyte Ratio; PLR = Platelet to Lymphocyte Ratio 
4. DISCUSSION 
There was a significant difference in several laboratory parameters before 
and after radiotherapy treatment. MCHC, total leucocyte, lymphocyte, and 
thrombocyte were significantly reduced. On the other side, eosinophil, 
basophil, neutrophil, monocyte, NLR, and PLR were significantly increased 
after radiotherapy treatment. Similar to our findings, a recent study that 
evaluates the hematologic biomarker in patients with NPC treated with 
intensity-modulated radiotherapy found that neutrophil, platelet, and 
lymphocyte count were significantly decreased after treatment, while NLR and 
PLR were significantly increased after treatment. It is argued that decreased 
neutrophil, platelet, and lymphocyte count were most likely due to 
malnutrition as an impact of poor oral intake and increased protein catabolism. 
On the other hand, increased NLR and PLR were most likely because of 
systemic inflammation and critical lymphopenia due to the treatment [8]. 
The previous study that analyzes the leukocyte and neutrophil counts in 
NPC patients found that initial hyperleukocytosis and neutrophilia were 
independent poor prognostic factors. It is because the patients with initial 
hyperleukocytosis or neutrophilia were more likely to be at an advanced 
disease stage and, therefore, have poorer survival. Moreover, initial 
hyperleukocytosis or neutrophilia could also be a sign of aggressive cancer 
because of its roles in tumor progression by altering the tumor 
microenvironment [9]. In general, inflammatory cells could enhance the 
proliferating and metastatic abilities of tumor cells. Therefore, the elevated 
level of inflammatory cells might affect prognosis adversely [6, 10]. 
CBC evaluation was very useful to predict the prognosis of NPC 
patients. A combination of CBC with TNM staging has been used as 
prognosis prediction in NPC and it shows higher prediction efficiency on 
the 5-year disease-specific survival (DSS) compare to the TNM staging 
system alone. The CBC parameter that was included in the scoring system 
was hemoglobin, NLR, and thrombocyte [11]. Other than as an independent 
prognostic factor for DSS, thrombocyte count was also an independent 
predictor of metastasis-free survival in patients with NPC [12]. It has been 
suggested that lymphocyte should also be considered as a prognostic marker 
that may reflect the immunological status of patients during and after 
treatment [13]. PLR and NLR pretreatment were also found to be a reliable 
predictor factor for overall survival, progression-free survival, disease-
specific survival, and distant metastasis-free survival [8, 14-17]. 
Other than systemic effect, radiotherapy also causes local side effects 
in the surrounding healthy tissue because oxidation of protein and lipids 
induced by the free radicals produced by exposure radiotherapy [18]. There 
are currently 2 scoring system for evaluating the late radiation toxicity, 
RTOG/EORTC and LENT/SOMA. These scores are specific for each organ 
tissue. However, there is no evaluation regarding the hematologic value [19, 
20]. For acute radiation toxicity, there is only RTOG/EORTC scoring 
systems. This scoring system has evaluation regarding the hematologic 
value, where the lower the hematologic evaluation value, the higher the 
radiation toxicity score [19]. 
5. CONCLUSION 
Radiotherapy had a significant effect on several CBC parameters in 
NPC patients. Future study needs to be done to determine whether the 
change is because of the regression or progression of the tumor or because 
of the radiotherapy effect solely. Moreover, there is also a need to evaluate 
the changes in all CBC parameters as prognostic factors for the 5-year 
survival rate in NPC patients. 
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